A health ministry panel of experts approved on Monday a third dose of the Pfizer coronavirus vaccine for children between the ages of 5 and 11.
The move is hoped to help prevent children in that age group from getting infected with COVID-19 and developing severe symptoms, as the nation continues to see high levels of coronavirus infections driven by the highly infectious BA.5 omicron subvariant.
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.
https://www.japantimes.co.jp/subscribe/?utm_source=jto&utm_medium=general-box&utm_campaign=sub” class=”general-box_sub”>SUBSCRIBE NOW
https://www.japantimes.co.jp/news/2022/08/29/national/science-health/astrazeneca-evusheld-approval/”>